The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, What Market Size Is The Transcatheter Embolization And Occlusion Devices Market Expected To Reach Based On Its 2026 Value?
The transcatheter embolization and occlusion devices market has experienced rapid expansion in recent years. This market is projected to expand from $5.23 billion in 2025 to $5.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.6%. Historically, this growth can be ascribed to several factors, including the increased scope of interventional radiology procedures, the growing incidence of vascular disorders, enhanced access to catheter-based therapies, the increasing acceptance of minimally invasive treatments, and advancements in imaging-guided intervention methods.
The transcatheter embolization and occlusion devices market is projected to experience robust expansion over the coming years. This market is anticipated to reach a value of $8.33 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.5%. Factors contributing to this growth during the forecast period include a heightened demand for targeted embolization treatments, a surge in the embrace of sophisticated embolic substances, the expansion of procedures in oncology and neurointervention, a greater emphasis on personalized medicine, and increased funding for interventional healthcare facilities. Key trends anticipated during this period encompass the growing integration of minimally invasive embolization methods, an escalating need for advanced liquid embolic solutions, a wider application of detachable and coated coils, the broadening scope of image-guided interventional approaches, and a stronger emphasis on precise occlusion technologies.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Key Drivers Are Affecting The Transcatheter Embolization And Occlusion Devices Market Development?
The rising demand for minimally invasive surgical techniques is projected to spur the expansion of the transcatheter embolization and occlusion devices market. Minimally invasive procedures involve using small cuts or robotic assistance to access internal body parts, thereby minimizing tissue damage, leading to less physical trauma, quicker recovery periods, reduced post-operative discomfort, and a decreased risk of complications. The growing appeal of these methods stems from progress in surgical technology, increased patient knowledge of less-invasive alternatives, and better clinical results. Transcatheter embolization and occlusion devices facilitate these minimally invasive interventions by offering precise, catheter-based treatment with minimal interference to surrounding tissues. For instance, in January 2025, Intuitive Surgical, Inc., a US-based medical technology corporation, reported that full-year 2024 worldwide da Vinci procedures saw an increase of approximately 17% compared with 2023. The company anticipates worldwide da Vinci procedures to grow by approximately 13% to 16% in 2025 compared with 2024. Consequently, the increasing adoption of minimally invasive techniques is propelling the growth of the transcatheter embolization and occlusion devices market.
How Is The Transcatheter Embolization And Occlusion Devices Market Organized By Segment Classification?
The transcatheter embolization and occlusion devices market covered in this report is segmented –
1) By Type: Coil, Non-Coil
2) By Application: Peripheral Vascular Disease, Oncology, Neurology, Urology, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Clinics, Other End Users
Subsegments:
1) By Coil: Bare Metal Coil, Surface Coated Coil, Detachable Coil
2) By Non-Coil: Gelatin Sponge, Liquid Embolic Agents, Spheres And Particles
What Trends Are Transforming The Transcatheter Embolization And Occlusion Devices Market?
Leading firms within the transcatheter embolization and occlusion devices market are concentrating on creating sophisticated solutions, specifically liquid embolic systems, in response to the growing need for less invasive vascular procedures and the effective management of arterial hemorrhage. This type of system is defined as a non-adhesive, polymer-based embolization technology, administered via a microcatheter, which hardens upon interacting with blood. It facilitates the controlled blocking of abnormal or compromised vessels, providing superior penetration and exactness compared to conventional coil-based approaches. An illustrative instance occurred in July 2025 when Medtronic plc., a US-based medical technology company, initiated clinical evaluation of its Onyx Liquid Embolic System (LES) through an IDE study, targeting the embolization of arterial hemorrhage within the peripheral vasculature. This particular innovation incorporates an ethylene-vinyl alcohol (EVOH) copolymer, dissolved in DMSO and combined with tantalum powder to ensure radiopacity, which enables medical professionals to monitor and guide its administration instantaneously. A cohesive embolus is formed as the solvent disperses, facilitating precise vessel occlusion while lessening the likelihood of catheter entrapment and enhancing safety in intricate anatomical structures. Intended for application in cases of active peripheral arterial bleeding, the system boosts precision, supports streamlined minimally invasive treatment processes, and broadens the range of therapeutic choices available to interventional specialists.
Who Are The Industry Participants Involved In The Transcatheter Embolization And Occlusion Devices Market?
Major companies operating in the transcatheter embolization and occlusion devices market are Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic Inc., Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Teleflex Incorporated, Cook Medical, Merit Medical Systems Inc., Penumbra Inc., Sirtex Medical Limited, Cordis Corporation, pfm medical ag, Micro Interventional Devices Inc., Acandis GmbH, Metactive Medical Inc., Balt Group, Kaneka Medix Corporation, Shape Memory Medical Inc., Boston Scientific Neurovascular
Get The Full Transcatheter Embolization And Occlusion Devices Market Report:
Where Is The Transcatheter Embolization And Occlusion Devices Market Primarily Concentrated By Region?
North America was the largest region in the transcatheter embolization and occlusion devices market in 2025. The regions covered in the transcatheter embolization and occlusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Transcatheter Embolization And Occlusion Devices Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Transcatheter Embolization And Occlusion Devices Market 2026, By The Business Research Company
Tumor Embolization Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report
Neurovascular Embolization Devices Market Report 2026
Vascular Embolization Market Report 2026
https://www.thebusinessresearchcompany.com/report/vascular-embolization-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model